Home Page |
References | OMIM | Gene | GeneReviews | HGMD | HGNC |
GENATLAS PHENOTYPE |
last update : 30-11-2009 |
Symbol | RSTS |
Location | 16p13.3 |
Name | Rubinstein-Taybi syndrome |
Other name(s) |
|
Corresponding gene | CREBBP |
Other symbol(s) | RTS, DEL16P13.3 |
Main clinical features |
|
Genetic determination | autosomal dominant |
chromosomal | |
Prevalence | estimated 1/125 000 livebirths, 50 p100 of RSTS patients (PMID: 19533794) |
Related entries | include severe RSTS (MIM 610543) |
Function/system disorder | multisystem/generalized |
mental retardation | |
Type | MCA/MR |
Gene product |
Name | CREB binding protein (CREBBP) transcriptional coactivator interacting with a number of proteins |
Mechanism(s) |
Gene mutation | Chromosome rearrangement | Effect | Comments |
| deletion
|  
| haploinsufficiency
| ~10 p100 of patients, detected by FISH using 5 cosmid probes spanning the 150 Kb of the CREEBBP gene
| missense
|  
| abnormal protein/loss of function
| mutations that affect only the HAT domain of CBP responsible of loss of HAT activity ( mutation R1664H, N1978S )
| abnormal splicing
|  
| abnormal protein/loss of function
| nonsense, missence and splicing mutations of CREBBP have been described in 35 p100 of patients
|  
| translocation
|  
| Some rare patients have apparently balanced translocations or inversions involving 16p13.3
|  
| deletion
|  
| submicroscopic deletions in 16p13
| |
Remark(s) | belongs to the group of "chromatin disorders" ; CREBBP mutations in 50 percent of cases |
Genotype/Phenotype correlations |
|